I wish the SEC had spoken up when JJ was pumping the HP for Ebola. I ended up missing out on $41k in prifit believibg they were going to treat more patients. Like I said before we found out after the fact that JJ sent the Neb Hospital HPs without requesting them, the Dr treated even questions tbe efficacy of his HP treatment since he had already been injected with every available Ebola drug in trial at the time and the Drs at hospitals which treated Ebola patients all questioned the results and don't believe it was the cauxe of his recovery. I
I was in the stock for 10 yrs and have heard all these uplifting stories before without tne device ever getting approved for market and not one device sold.
Look back at the Darpa contract to create a field device to treat sepsis, AEMD never produced a device to treat Sepsis.
Developments, Trials, experiments, tail chasing is all I've seen in over 14 yrs.
Just because you can lower the viral count doesn't mean it's a cure and the fact it needs expensive blood pumping equipment means it's not going to be readily available in most places especially where it's most needed.
I don't mean to be " Debbie Downer or Negative Nancy" but I have seen this play out before. Pump it and dilute, pump it and dilute, pump it and dilute, reverse splits, go to Nasdaq and drop, drop drop while diluting.
AI
Market Data 
Markets 
